US FDA ‘Flexible’ With Vaccine Safety Data Requirements, CBER’s Peter Marks Says

 
• By Derrick Gingery

The median of two months of follow-up is not absolute, but agency flexibility is limited.

Marks_Peter in basement_1200 - CBER Director - JAMA event 5 October 2020
Relegated to the basement after his previous broadcasting perch became a college classzoom, CBER Director Peter Marks still dispenses wisdom and reassurance. What his new location lacks in ambiance it makes up for in the absence of dog interruptions. • Source: screenshot of JAMA webcast

More from Vaccines

More from Pink Sheet